Galderma Announces Triple Approval of New State-of-the-Art Restylane® Syringe in the EU, the U.S., and Canada, Reaffirming the Company’s Position at the Forefront of Injectable Aesthetics

2026-02-25 - 06:13

https://mms.businesswire.com/media/20260224651688/en/2729498/19/022326_Restylane_NGS_social_and_multimedia_asset_v3_0.mp4 Read More